Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sinusitis | 14 | 2020 | 649 | 3.53 | Why? |
| Rhinitis | 12 | 2018 | 626 | 2.63 | Why? |
| Food Hypersensitivity | 3 | 2020 | 397 | 1.55 | Why? |
| Rhinitis, Allergic | 3 | 2020 | 704 | 1.41 | Why? |
| Asthma | 8 | 2020 | 4383 | 1.40 | Why? |
| Eczema | 2 | 2020 | 227 | 1.29 | Why? |
| Hypersensitivity | 3 | 2020 | 1137 | 1.13 | Why? |
| Microbiota | 5 | 2018 | 1240 | 0.90 | Why? |
| Dermatitis, Atopic | 2 | 2018 | 714 | 0.80 | Why? |
| Sleep Apnea, Obstructive | 2 | 2018 | 668 | 0.76 | Why? |
| Nocturnal Myoclonus Syndrome | 1 | 2018 | 10 | 0.74 | Why? |
| Sleep Disorders, Intrinsic | 1 | 2017 | 4 | 0.70 | Why? |
| Dietary Fiber | 1 | 2017 | 73 | 0.67 | Why? |
| Polysomnography | 1 | 2018 | 296 | 0.63 | Why? |
| Nasal Obstruction | 1 | 2017 | 131 | 0.61 | Why? |
| Gastrointestinal Microbiome | 2 | 2018 | 1961 | 0.55 | Why? |
| Nasal Mucosa | 2 | 2018 | 1218 | 0.53 | Why? |
| Cholangitis, Sclerosing | 1 | 2015 | 106 | 0.51 | Why? |
| Education, Medical, Continuing | 1 | 2020 | 638 | 0.50 | Why? |
| Paranasal Sinuses | 3 | 2021 | 217 | 0.48 | Why? |
| Chronic Disease | 13 | 2018 | 5139 | 0.48 | Why? |
| Common Variable Immunodeficiency | 1 | 2015 | 195 | 0.47 | Why? |
| Nose | 1 | 2018 | 1093 | 0.44 | Why? |
| Nasal Polyps | 5 | 2018 | 221 | 0.37 | Why? |
| African Americans | 2 | 2020 | 3363 | 0.35 | Why? |
| Eosinophilia | 4 | 2018 | 292 | 0.33 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.33 | Why? |
| Diet | 2 | 2018 | 2052 | 0.32 | Why? |
| Gastrointestinal Diseases | 1 | 2022 | 2580 | 0.32 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.32 | Why? |
| Poverty | 1 | 2017 | 2302 | 0.30 | Why? |
| Olfaction Disorders | 3 | 2021 | 3704 | 0.29 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.27 | Why? |
| Albuterol | 1 | 2020 | 105 | 0.20 | Why? |
| Pancreas | 2 | 2020 | 398 | 0.19 | Why? |
| Sulfides | 1 | 2020 | 113 | 0.19 | Why? |
| Bacteroidetes | 1 | 2018 | 36 | 0.19 | Why? |
| Firmicutes | 1 | 2018 | 41 | 0.19 | Why? |
| Histamine Antagonists | 1 | 2020 | 203 | 0.19 | Why? |
| Lipase | 1 | 2020 | 153 | 0.19 | Why? |
| Illinois | 2 | 2017 | 468 | 0.18 | Why? |
| Acetates | 1 | 2020 | 123 | 0.18 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 100 | 0.18 | Why? |
| Intubation | 1 | 2020 | 437 | 0.18 | Why? |
| Biodiversity | 2 | 2018 | 546 | 0.18 | Why? |
| Ethmoid Sinus | 1 | 2017 | 10 | 0.18 | Why? |
| South Africa | 2 | 2018 | 3326 | 0.17 | Why? |
| Cyclopropanes | 1 | 2020 | 332 | 0.17 | Why? |
| Asthma, Aspirin-Induced | 1 | 2017 | 15 | 0.17 | Why? |
| Chicago | 1 | 2020 | 653 | 0.17 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.17 | Why? |
| Comorbidity | 5 | 2022 | 34796 | 0.15 | Why? |
| Cohort Studies | 5 | 2020 | 36005 | 0.15 | Why? |
| Female | 23 | 2021 | 380317 | 0.15 | Why? |
| Raltegravir Potassium | 1 | 2016 | 132 | 0.15 | Why? |
| Male | 21 | 2021 | 367725 | 0.15 | Why? |
| Quinolines | 1 | 2020 | 403 | 0.15 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.15 | Why? |
| Radiation Injuries | 1 | 2017 | 140 | 0.15 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.15 | Why? |
| Drug Hypersensitivity Syndrome | 1 | 2016 | 74 | 0.15 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.15 | Why? |
| Anti-Asthmatic Agents | 1 | 2020 | 427 | 0.14 | Why? |
| Humans | 31 | 2022 | 930598 | 0.14 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.14 | Why? |
| Prednisone | 1 | 2018 | 652 | 0.14 | Why? |
| Alkaline Phosphatase | 1 | 2015 | 257 | 0.13 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.12 | Why? |
| Eosinophils | 1 | 2018 | 848 | 0.12 | Why? |
| Severity of Illness Index | 7 | 2021 | 48226 | 0.11 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.11 | Why? |
| Adult | 12 | 2021 | 244371 | 0.11 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.10 | Why? |
| Anti-Inflammatory Agents | 2 | 2020 | 6153 | 0.10 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.10 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.09 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.09 | Why? |
| Body Mass Index | 2 | 2020 | 4306 | 0.09 | Why? |
| Alanine Transaminase | 1 | 2015 | 1329 | 0.09 | Why? |
| Income | 1 | 2017 | 1564 | 0.09 | Why? |
| Aged | 10 | 2020 | 215776 | 0.09 | Why? |
| Aspartate Aminotransferases | 1 | 2015 | 1394 | 0.09 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.08 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.08 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.08 | Why? |
| Postoperative Period | 2 | 2018 | 651 | 0.08 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.08 | Why? |
| Infant | 2 | 2020 | 30274 | 0.07 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.07 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.07 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.07 | Why? |
| Immunoglobulin A | 1 | 2015 | 3567 | 0.06 | Why? |
| Child | 4 | 2020 | 70012 | 0.06 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Disease Progression | 2 | 2018 | 13580 | 0.06 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.06 | Why? |
| Obesity | 2 | 2020 | 7388 | 0.06 | Why? |
| Colorectal Neoplasms | 1 | 2014 | 1884 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.05 | Why? |
| Metaplasia | 1 | 2018 | 43 | 0.05 | Why? |
| Retrospective Studies | 4 | 2018 | 105322 | 0.05 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.05 | Why? |
| Mice, Inbred NOD | 1 | 2018 | 134 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.05 | Why? |
| Mice, SCID | 1 | 2018 | 225 | 0.05 | Why? |
| Chemokine CCL11 | 1 | 2017 | 11 | 0.04 | Why? |
| Eosinophil Cationic Protein | 1 | 2017 | 4 | 0.04 | Why? |
| Lysophospholipase | 1 | 2017 | 5 | 0.04 | Why? |
| Basement Membrane | 1 | 2017 | 30 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| RAW 264.7 Cells | 1 | 2018 | 316 | 0.04 | Why? |
| Cyclooxygenase Inhibitors | 1 | 2017 | 46 | 0.04 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 112 | 0.04 | Why? |
| Precancerous Conditions | 1 | 2018 | 108 | 0.04 | Why? |
| Immunoglobulin M | 1 | 2015 | 9091 | 0.04 | Why? |
| Interleukin-5 | 1 | 2017 | 138 | 0.04 | Why? |
| Endoscopy | 2 | 2018 | 1564 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Carcinogenesis | 1 | 2018 | 236 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Turbinates | 1 | 2017 | 205 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.04 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.03 | Why? |
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 67 | 0.03 | Why? |
| United States | 2 | 2020 | 46150 | 0.03 | Why? |
| Edema | 1 | 2017 | 333 | 0.03 | Why? |
| Fibrosis | 1 | 2017 | 800 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Depression | 1 | 2017 | 14116 | 0.03 | Why? |
| Glycoproteins | 1 | 2017 | 615 | 0.03 | Why? |
| Drug Eruptions | 1 | 2016 | 319 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2015 | 21571 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Taste Disorders | 1 | 2021 | 1720 | 0.02 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.02 | Why? |
| Leukocyte Count | 1 | 2018 | 3178 | 0.02 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Environment | 1 | 2014 | 769 | 0.02 | Why? |
| Intestines | 1 | 2014 | 817 | 0.02 | Why? |
| Epigenesis, Genetic | 1 | 2014 | 711 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Phenotype | 1 | 2014 | 4037 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.01 | Why? |
| Prospective Studies | 2 | 2017 | 43301 | 0.01 | Why? |
| Feeding Behavior | 1 | 2014 | 1909 | 0.01 | Why? |
| Life Style | 1 | 2014 | 2708 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Developing Countries | 1 | 2014 | 4283 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Global Health | 1 | 2014 | 13911 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Mahdavinia's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_